Management of stable chronic obstructive pulmonary disease

Abstract

Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death in the United States and is a major cause of disability. The recently updated Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines address the management of stable COPD. Management of symptoms can decrease exacerbation risk and limit emergency room and hospital visits. As part of the multidisciplinary team, pharmacists can be an invaluable resource in educating patients about the disease and the proper administration of medications. Pharmacists can also have an active role in nonpharmacologic treatments such as smoking cessation and vaccine administration.